AI Terminal
Oxford Biomedica PLC
Share Issue/Capital Change • Jan 2, 2025
5190_rns_2025-01-02_e8648ba8-46f4-4644-8ad9-4b588ee877c1.html
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 8214R
Oxford Biomedica PLC
02 January 2025
| For Immediate Release | 2 January 2025 |
OXFORD BIOMEDICA PLC
BLOCK LISTING RETURN
| Name of applicant: | OXFORD BIOMEDICA PLC | |||
| Name of scheme: | 2015 Employee Share Option Scheme | |||
| Period of return: | From: | 1 July 2024 | To: | 31 December 2024 |
| Balance of unallotted securities under scheme(s) from previous return: | 294,719 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | NIL | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 11,197 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 283,522 | |||
| Name of applicant: | OXFORD BIOMEDICA PLC | |||
| Name of scheme: | 2015 and 2024 Long Term Incentive Plan | |||
| Period of return: | From: | 1 July 2024 | To: | 31 December 2024 |
| Balance of unallotted securities under scheme(s) from previous return: | 393,299 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 600,000 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 433,280 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 560,019 | |||
| Name of applicant: | OXFORD BIOMEDICA PLC | |||
| Name of scheme: | 2015 and 2024 Deferred Bonus Plan | |||
| Period of return: | From: | 1 July 2024 | To: | 31 December 2024 |
| Balance of unallotted securities under scheme(s) from previous return: | 286,791 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 300,000 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 211,730 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 375,061 | |||
| Name of applicant: | OXFORD BIOMEDICA PLC | |||
| Name of scheme: | Sharesave Scheme | |||
| Period of return: | From: | 1 July 2024 | To: | 31 December 2024 |
| Balance of unallotted securities under scheme(s) from previous return: | 339,753 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | NIL | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 713 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 339,040 | |||
| Name of contact: | Natalie Walter, Company Secretary |
| Telephone number of contact: | 01865 783000 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BLRUAUNRVSUARAR